Key statistics
As of last trade Teleflex Inc (TFX:NYQ) traded at 121.77, -15.04% below its 52-week high of 143.32, set on Mar 24, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 120.10 |
|---|---|
| High | 122.28 |
| Low | 116.31 |
| Bid | 121.68 |
| Offer | 121.85 |
| Previous close | 122.93 |
| Average volume | 1.24m |
|---|---|
| Shares outstanding | 44.20m |
| Free float | 43.99m |
| P/E (TTM) | 99.15 |
| Market cap | 5.43bn USD |
| EPS (TTM) | 1.24 USD |
| Annual div (ADY) | 1.36 USD |
|---|---|
| Annual div yield (ADY) | 1.11% |
| Div ex-date | Nov 14 2025 |
| Div pay-date | Dec 15 2025 |
| Next div ex-date | Mar 06 2026 |
| Next div pay-date | Mar 31 2026 |
Data delayed at least 15 minutes, as of Mar 03 2026 20:16 GMT.
More ▼
- Teleflex Announces Leadership Transition
- Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion
- Teleflex to Present at the Jefferies Global Healthcare Conference in London
- Teleflex Announces Quarterly Dividend
- Teleflex Reports Third Quarter Financial Results and Full Year 2025 Outlook
- Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details
- First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients
- Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
- Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a Proven Safe and Effective Option to Minimize the Harmful Long-Term Side Effects of Prostate Radiation Therapy
- Teleflex Announces Quarterly Dividend
More ▼
